These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31657109)
1. Local release of metalloproteinases and their inhibitors after a successful revascularisation procedure. Grande R; Brachini G; Sterpetti AV; Borrelli V; Serra R; Pugliese F; D'Ermo G; Tartaglia E; Rubino P; Mingoli A; Sapienza P Int Wound J; 2020 Feb; 17(1):149-157. PubMed ID: 31657109 [TBL] [Abstract][Full Text] [Related]
2. [Protein expressions of matrix metalloproteinase-9 and its inhibitor and their ratio changes in wound healing of patients with stages Ⅲ and Ⅳ pressure ulcers]. Wang Y; Li X; Zhao W; Gao ZZ; Zheng MJ; Pang YL; Chen ZY Zhonghua Shao Shang Za Zhi; 2019 Oct; 35(10):746-751. PubMed ID: 31658546 [No Abstract] [Full Text] [Related]
3. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Liu Z; Dumville JC; Hinchliffe RJ; Cullum N; Game F; Stubbs N; Sweeting M; Peinemann F Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010318. PubMed ID: 30328611 [TBL] [Abstract][Full Text] [Related]
4. Different inflammatory cytokines release after open and endovascular reconstructions influences wound healing. Sapienza P; Mingoli A; Borrelli V; Grande R; Sterpetti AV; Biacchi D; Ferrer C; Rubino P; Serra R; Tartaglia E Int Wound J; 2019 Aug; 16(4):1034-1044. PubMed ID: 31158921 [TBL] [Abstract][Full Text] [Related]
5. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Ladwig GP; Robson MC; Liu R; Kuhn MA; Muir DF; Schultz GS Wound Repair Regen; 2002; 10(1):26-37. PubMed ID: 11983004 [TBL] [Abstract][Full Text] [Related]
6. Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN). Okuda K; Miyazaki A; Momose M; Murata M; Nomura T; Kubota T; Wolff LF; Yoshie H J Periodontal Res; 2001 Oct; 36(5):309-16. PubMed ID: 11585118 [TBL] [Abstract][Full Text] [Related]
7. Effect of negative pressure wound therapy on molecular markers in diabetic foot ulcers. Karam RA; Rezk NA; Abdel Rahman TM; Al Saeed M Gene; 2018 Aug; 667():56-61. PubMed ID: 29758297 [TBL] [Abstract][Full Text] [Related]
8. Expression of MMP-8 in Pressure Injuries in Spinal Cord Injury Patients Managed by Negative Pressure Wound Therapy or Conventional Wound Care: A Randomized Controlled Trial. Dwivedi MK; Bhagat AK; Srivastava RN; Jain A; Baghel K; Raj S J Wound Ostomy Continence Nurs; 2017; 44(4):343-349. PubMed ID: 28459717 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Muller M; Trocme C; Lardy B; Morel F; Halimi S; Benhamou PY Diabet Med; 2008 Apr; 25(4):419-26. PubMed ID: 18387077 [TBL] [Abstract][Full Text] [Related]
10. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. Tüter G; Kurtiş B; Serdar M J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249 [TBL] [Abstract][Full Text] [Related]
11. A multistage combined approach to promote diabetic wound healing in COVID-19 era. Grande R; Fiori G; Russo G; Fioramonti P; Campagnol M; di Marzo L Int Wound J; 2020 Dec; 17(6):1863-1870. PubMed ID: 32820598 [TBL] [Abstract][Full Text] [Related]
12. Polarized Secretion of Matrix Metalloproteinases and Their Inhibitors by Retinal Pigment Epithelium Derived from Induced Pluripotent Stem Cells During Wound Healing. Greene WA; Burke TA; Kaini RR; Por ED; Wang HC J Ocul Pharmacol Ther; 2017 Apr; 33(3):132-140. PubMed ID: 28384031 [TBL] [Abstract][Full Text] [Related]
13. An MMP/TIMP ratio scoring system as a potential predictive marker of diabetic foot ulcer healing. Luanraksa S; Jindatanmanusan P; Boonsiri T; Nimmanon T; Chaovanalikit T; Arnutti P J Wound Care; 2018 Dec; 27(12):849-855. PubMed ID: 30557113 [TBL] [Abstract][Full Text] [Related]
14. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Vaalamo M; Leivo T; Saarialho-Kere U Hum Pathol; 1999 Jul; 30(7):795-802. PubMed ID: 10414498 [TBL] [Abstract][Full Text] [Related]
16. Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid*. Subramaniam K; Pech CM; Stacey MC; Wallace HJ Int Wound J; 2008 Mar; 5(1):79-86. PubMed ID: 18336381 [TBL] [Abstract][Full Text] [Related]